Research is part of our care
CureRays is committed to advancing the science of radiation medicine. Through clinical trials and investigational protocols, we study new ways to cure cancer with less burden, expand radiation's role in benign and inflammatory conditions, and bring innovative options closer to home.
Research focus areas
- Hypofractionated and stereotactic radiation (fewer, more precise treatments)
- Low-dose radiation therapy (LDRT) for inflammatory conditions
- Whole-lung LDRT (studied in COVID-19-related pneumonia — Best of ASTRO recognition)
- Survivorship and after-cancer care strategies
- Global-health collaborations, including cervical-cancer treatment in rural Brazil
Clinical Research
- Basal Cell Carcinoma
- Squamous Cell Carcinoma
- Cutaneous Melanoma
- Merkel Cell Carcinoma
- Pre-Cancerous Skin Lesions
- Benign Skin Lesions
- Keloids
- Refractory Psoriasis
- Osteoarthritis
- COVID-19 Pneumonia
Ask about enrolling
Eligibility for a clinical trial depends on your diagnosis, prior treatment, and overall health. If you're interested in participating, our team can review current studies with you and explain what each involves.
Watch: the SABR-COMET trial
A plain-language walkthrough of the SABR-COMET randomised trial and what it showed about treating a small number of metastases with stereotactic radiation.
Interested in a trial?
Contact our research team to learn what's currently enrolling.